Dong-A St
Dong-A ST Co., Ltd. develops, manufactures, and markets pharmaceutical products in South Korea and internationally. It offers various ethical drugs, including Clofazimine cap. For lepromatous leprosy; Closerin Cap for active pulmonary and extra-pulmonary tuberculosis; Eporon inj./PFS for anemia associated with chronic renal failure; Gemcit inj. to treat non-small cell lung, pancreatic, breast, bl… Read more
Market Cap & Net Worth: Dong-A St (170900)
Dong-A St (KO:170900) has a market capitalization of $272.23 Million (₩398.60 Billion) as of March 18, 2026. Listed on the KO stock exchange, this Korea-based company holds position #16644 globally and #528 in its home market, demonstrating a -11.85% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dong-A St's stock price ₩43500.00 by its total outstanding shares 9163209 (9.16 Million).
Dong-A St Market Cap History: 2015 to 2026
Dong-A St's market capitalization history from 2015 to 2026. Data shows change from $819.51 Million to $272.23 Million (-8.21% CAGR).
Dong-A St Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Dong-A St's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Dong-A St's market cap is 0.00 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $819.51 Million | $567.94 Billion | $48.56 Billion | 0.00x | 0.02x |
| 2016 | $591.40 Million | $560.54 Billion | $10.63 Billion | 0.00x | 0.06x |
| 2017 | $561.18 Million | $555.03 Billion | -$5.40 Billion | 0.00x | N/A |
| 2018 | $594.34 Million | $567.43 Billion | $8.01 Billion | 0.00x | 0.07x |
| 2019 | $682.64 Million | $612.31 Billion | $70.91 Billion | 0.00x | 0.01x |
| 2020 | $514.25 Million | $586.73 Billion | $27.10 Billion | 0.00x | 0.02x |
| 2021 | $421.39 Million | $593.23 Billion | $12.82 Billion | 0.00x | 0.03x |
| 2022 | $369.14 Million | $635.39 Billion | $13.55 Billion | 0.00x | 0.03x |
| 2023 | $432.44 Million | $663.98 Billion | $11.12 Billion | 0.00x | 0.04x |
| 2024 | $367.98 Million | $697.87 Billion | -$1.22 Billion | 0.00x | N/A |
Competitor Companies of 170900 by Market Capitalization
Companies near Dong-A St in the global market cap rankings as of March 18, 2026.
Key companies related to Dong-A St by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Dong-A St Historical Marketcap From 2015 to 2026
Between 2015 and today, Dong-A St's market cap moved from $819.51 Million to $ 272.23 Million, with a yearly change of -8.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩272.23 Million | -17.14% |
| 2025 | ₩328.55 Million | -10.71% |
| 2024 | ₩367.98 Million | -14.91% |
| 2023 | ₩432.44 Million | +17.15% |
| 2022 | ₩369.14 Million | -12.40% |
| 2021 | ₩421.39 Million | -18.06% |
| 2020 | ₩514.25 Million | -24.67% |
| 2019 | ₩682.64 Million | +14.86% |
| 2018 | ₩594.34 Million | +5.91% |
| 2017 | ₩561.18 Million | -5.11% |
| 2016 | ₩591.40 Million | -27.84% |
| 2015 | ₩819.51 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Dong-A St was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $272.23 Million USD |
| MoneyControl | $272.23 Million USD |
| MarketWatch | $272.23 Million USD |
| marketcap.company | $272.23 Million USD |
| Reuters | $272.23 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.